Finasteride Cost in Texas 2026: Cash Price, Insurance, Medicaid, and Compounded Options

What Does Finasteride Actually Cost in Texas Right Now?

Generic finasteride runs about $12 per month cash-pay at Texas retail pharmacies in 2026, while Merck's branded Propecia carries a list price near $85 per month. The gap exists because finasteride lost patent exclusivity years ago, and Texas has dozens of competing generic manufacturers driving prices down. A 30-tablet supply of 1 mg generic finasteride at CVS, Walgreens, HEB, and Walmart in Texas typically falls between $10 and $18 without any coupon or discount card.

Propecia (brand-name finasteride 1 mg) and Proscar (finasteride 5 mg for BPH) are the two FDA-approved formulations. The FDA approved Proscar (finasteride 5 mg) in 1992 for benign prostatic hyperplasia and Propecia (finasteride 1 mg) in 1997 for androgenetic alopecia. [1] Because a 5 mg tablet can be split into roughly five 1 mg doses, some patients use the BPH-dose tablet as a cost-cutting strategy. That practice is off-label, and patients should confirm the approach with their prescriber before splitting tablets.

The Kaufman et al. trial published in the Journal of the American Academy of Dermatology (N=1,553) demonstrated that finasteride 1 mg daily produced statistically significant hair count improvements vs. placebo over 48 weeks, establishing the evidence base that made the drug a first-line option for male androgenetic alopecia. P<0.001 for hair count increase vs. placebo at 48 weeks. [2] That evidence base means clinicians have decades of dosing data to draw from when counseling Texas patients on cost-effective strategies.

For patients with BPH, the NIH-supported literature on 5-alpha reductase inhibitors confirms finasteride 5 mg as a standard medical therapy, which matters for insurance coverage discussions covered below. [3]

Texas Medicaid and Finasteride: What the Formulary Actually Says

Texas Medicaid does not cover finasteride for androgenetic alopecia (male pattern hair loss). Coverage for the BPH indication (finasteride 5 mg) is formulary-dependent and subject to prior authorization under the Texas Health and Human Services STAR and STAR+PLUS managed care programs.

The Texas Vendor Drug Program (VDP) determines which drugs appear on the Texas Medicaid formulary. According to Texas Health and Human Services formulary guidance, cosmetic or appearance-related indications are categorically excluded from Medicaid reimbursement under federal Medicaid statute 42 U.S.C. § 1396r-8(d)(2). [4] Hair loss falls into that exclusion. That is a hard coverage wall, not a prior-authorization hurdle that a well-written appeal can clear.

BPH coverage under Texas Medicaid is a different story. Finasteride 5 mg appears on some managed care organization formularies as a preferred generic, though step-therapy requirements (trial of an alpha-blocker first) are common. Patients enrolled in STAR+PLUS who have a confirmed BPH diagnosis should ask their plan's pharmacy benefits manager specifically about finasteride 5 mg preferred tier status. The American Urological Association BPH guideline and NIH guidance on BPH pharmacotherapy both list 5-alpha reductase inhibitors as appropriate for larger prostates (>30 mL) or elevated PSA, which strengthens a medical necessity argument. [5]

A 2021 analysis in JAMA Internal Medicine noted that Medicaid drug coverage exclusions for cosmetic indications affect millions of patients nationally, often displacing cost to out-of-pocket or manufacturer assistance programs. [6] For Texas AGA patients on Medicaid, that cost displacement means cash-pay generics and discount programs are the practical route.

Compounded Finasteride in Texas: Legality and What to Expect

Compounded finasteride from a Texas-licensed 503A pharmacy is legal. State law requires these pharmacies to operate under Texas State Board of Pharmacy (TSBP) oversight, which includes verification of pharmacist licensure, drug purity standards, and patient-specific prescription requirements.

The FDA's guidance on 503A compounding pharmacies outlines the federal framework within which state boards like TSBP operate. [7] A 503A pharmacy compounds for individual patients based on a valid prescription. This differs from a 503B outsourcing facility, which compounds in bulk without patient-specific prescriptions. For finasteride, the 503A route is the standard path in Texas telehealth and specialty men's health practices.

Compounded finasteride in Texas typically costs around $45 per month. That price sits above the generic retail cash price of $12 per month but below the brand-name list price of $85. Why would a patient choose the more expensive compounded option? Some telehealth platforms bundle compounded finasteride with minoxidil or other actives in a single formulation. Others offer liquid or topical compounded finasteride, which may reduce systemic absorption and potentially lower the risk of sexual side effects, though the evidence on topical finasteride systemic exposure compared to oral is still accumulating. [8]

The TSBP prohibits compounding of commercially available drugs unless there is a documented clinical reason the commercial product does not meet the patient's needs. Finasteride 1 mg tablets are commercially available, so a prescriber writing for compounded finasteride should document the clinical rationale, such as a swallowing difficulty, a specific dose that differs from commercial strengths, or a combination formulation. Telehealth platforms operating in Texas should build that documentation into their intake workflow.

One practical point: compounded finasteride is not FDA-approved. The FDA's position on compounded drugs is that they lack the agency's safety and efficacy review. [9] Patients deserve that disclosure before choosing a compounded product over a generic tablet that costs $12 per month and carries decades of clinical data.

Insurance Coverage for Finasteride in Texas: Commercial Plans

Commercial insurance coverage for finasteride in Texas depends heavily on the indication documented on the prescription and the specific plan's formulary tier.

For BPH (finasteride 5 mg), most Texas commercial plans including those sold through Blue Cross Blue Shield of Texas, Aetna, Cigna, and UnitedHealthcare place generic finasteride on Tier 1 or Tier 2, with copays ranging from $0 to $15 per month after the deductible. The AUA BPH clinical guideline explicitly recommends 5-alpha reductase inhibitors for appropriate patients, giving insurers a clear medical necessity anchor. [10]

For AGA (finasteride 1 mg), coverage is inconsistent. Many plans categorically exclude drugs prescribed for cosmetic purposes. The Kaiser Family Foundation's analysis of ACA-compliant plan formularies confirms that cosmetic-indication exclusions are common and legal under the ACA's essential health benefit framework. [11] When a prescriber writes "androgenetic alopecia" on the script, the plan's pharmacy benefit management system frequently auto-rejects it as cosmetic. Writing "hair loss secondary to hormonal imbalance" or documenting concurrent psychological impact does not reliably overturn that rejection. Patients should call the member services number on their insurance card before filling the prescription to verify coverage.

Employer-sponsored plans in Texas sometimes offer more generous formularies than individual market plans. Texas employees in large self-funded ERISA plans should check with their HR benefits coordinator, as ERISA plans are not bound by Texas Department of Insurance mandates and can structure formularies more broadly. The Texas Department of Insurance maintains public resources on pharmacy benefit plan requirements. [12]

The Cheapest Ways to Get Finasteride in Texas

Generic finasteride at $12 per month cash-pay is already close to the floor for oral tablet pricing, but several programs can cut that cost further.

GoodRx and similar discount platforms. GoodRx codes at Texas Walmart, Costco, and HEB pharmacies have shown finasteride 1 mg (30 tablets) as low as $7 to $9 per month in recent pricing data. These coupons cannot be combined with insurance but work for any cash-pay patient. The FDA's general guidance on patient assistance options acknowledges third-party discount programs as a legitimate access pathway. [13]

Merck Patient Assistance Program. Merck's patient assistance program (PAP) may provide branded Propecia at no cost to patients who meet income eligibility criteria, typically at or below 200 to 400 percent of the federal poverty level. Applications go through NeedyMeds or directly through Merck's program portal. Given that generic finasteride is $12 per month, the practical benefit of brand-name PAP assistance is limited for most patients unless they specifically require the Merck formulation.

340B program. Federally qualified health centers (FQHCs) and other 340B-covered entities in Texas can dispense finasteride at 340B pricing for eligible patients. The Health Resources and Services Administration oversees 340B program compliance. [14] Patients receiving primary care at an FQHC in Houston, Dallas, San Antonio, or Austin may access finasteride at significantly reduced cost through the 340B channel.

Splitting 5 mg tablets. As noted above, finasteride 5 mg (Proscar generic) can cost less per milligram than 1 mg tablets. A 30-day supply of generic finasteride 5 mg often runs $10 to $15, and splitting each tablet yields a five-month supply of 1 mg daily doses for roughly $2 to $3 per month. This approach requires a prescriber's explicit authorization and a pill splitter. The NIH's drug information portal confirms finasteride 5 mg and 1 mg as the two approved doses, though splitting is off-label for the AGA indication. [15]

The HealthRX Texas Finasteride Cost Decision Framework below summarizes the four pathways by monthly cost and patient profile:

| Pathway | Est. Monthly Cost | Best For | |---|---|---| | Generic 1 mg cash-pay (GoodRx) | $7, $12 | Most patients; fastest access | | Split generic 5 mg (off-label, with prescriber OK) | $2, $3 | Cost-sensitive patients; prescriber must document | | Compounded finasteride (503A telehealth) | $40, $50 | Topical/liquid preference; combination formulations | | Brand Propecia (insurance or PAP) | $0, $20 copay | Patients with Tier 1 BPH coverage or PAP eligibility |

Telehealth Prescribing of Finasteride in Texas

Texas law permits telehealth prescribing of finasteride. The Texas Medical Board's telemedicine rules, codified under Texas Occupations Code Chapter 111, allow a physician or mid-level provider licensed in Texas to establish a valid patient-provider relationship via synchronous video visit and issue a finasteride prescription. The Texas Medical Board's telehealth resource page outlines these requirements. [16]

Asynchronous or questionnaire-only prescribing platforms occupy a grayer legal zone under Texas rules. The Texas Medical Board has signaled that asynchronous encounters require sufficient clinical information to meet the standard of care, a bar that some questionnaire-only platforms may not clear. Patients using telehealth platforms to obtain finasteride in Texas should confirm that their visit includes a synchronous video or phone component, or that the platform has received specific Texas Medical Board guidance on its model.

Telehealth finasteride prescribing typically includes a baseline PSA discussion. The FDA's finasteride prescribing information notes that finasteride suppresses PSA by approximately 50 percent, which affects prostate cancer screening interpretation. [17] Any Texas prescriber, telehealth or in-person, should document that this counseling occurred. The Prostate Cancer Foundation's clinical guidance recommends doubling the PSA value in patients on finasteride when interpreting screening results.

The American Hair Loss Association recognizes finasteride 1 mg as the most effective FDA-approved medical treatment for male pattern hair loss, a position consistent with the American Academy of Dermatology's clinical practice guideline on AGA. [18] That consensus makes telehealth finasteride prescribing straightforward for straightforward AGA cases without complicating factors.

Side Effects, Monitoring, and the Post-Finasteride Syndrome Debate

Sexual side effects are the most discussed risk of finasteride. The original prescribing label reported sexual dysfunction (decreased libido, erectile dysfunction, ejaculatory disorder) in approximately 3.8 percent of men taking finasteride 1 mg vs. 2.1 percent on placebo. The FDA label for Propecia carries a warning that some patients report persistent sexual dysfunction after discontinuation. [19]

A 2011 paper in the Journal of Sexual Medicine described persistent sexual side effects in a subset of men after stopping finasteride. The condition is sometimes called post-finasteride syndrome (PFS). [20] The FDA added a label update in 2012 to reflect reports of persistent effects. Whether PFS represents a distinct pharmacological entity or has other etiologies remains debated in the literature.

The National Institutes of Health's ClinicalTrials.gov lists ongoing research into post-finasteride syndrome, and the Post-Finasteride Syndrome Foundation has submitted petitions to the FDA for a more prominent warning. Texas patients considering finasteride deserve a candid discussion of this data before starting therapy, including the baseline incidence of sexual dysfunction in the general population of men the same age.

Monitoring while on finasteride includes annual PSA checks (remembering the 50 percent suppression effect) and patient-reported symptom review. No routine bloodwork beyond PSA is required in standard clinical guidelines for AGA treatment. The NIH's MedlinePlus entry on finasteride provides lay-language monitoring guidance consistent with prescriber labeling. [21]

Finasteride for Women in Texas: Cost and Coverage Considerations

Finasteride is not FDA-approved for women and carries a Pregnancy Category X designation. Women who are or may become pregnant must not handle crushed or broken finasteride tablets due to risk of fetal harm, specifically ambiguous genitalia in a male fetus. The FDA's teratogenicity warning is absolute in this regard. [22]

Off-label use in postmenopausal women with AGA is described in the dermatology literature. A study published in the Journal of the American Academy of Dermatology (2000) evaluated finasteride 1 mg in postmenopausal women with AGA and found no statistically significant benefit vs. placebo, though subsequent research with higher doses (2.5 mg to 5 mg) in specific subgroups has shown variable results. [23] Insurance coverage for off-label female use is almost uniformly unavailable through Texas commercial or Medicaid plans, making cash-pay or PAP the default access pathway.

Texas women considering finasteride off-label should see a board-certified dermatologist or endocrinologist with documentation of hormonal evaluation, given that female AGA often coexists with conditions such as polycystic ovary syndrome (PCOS) that require separate management. The Endocrine Society's PCOS guideline outlines the hormonal workup appropriate before initiating anti-androgen therapy in women. [24]

How Texas Prices Compare to National Averages

The $12 per month Texas cash-pay price for generic finasteride 1 mg is consistent with national generic pricing. The FDA's Center for Drug Evaluation and Research drug competition reports document that generic entry typically reduces drug prices by 80 to 85 percent within five years of patent expiration. [25] Finasteride's original patents expired in the early 2000s, and the drug has been generic for over two decades, explaining the deep discount from the $85 brand-name list price.

State-by-state variation in pharmacy cash prices for finasteride is generally narrow, within $3 to $5 per month for a 30-tablet supply across most states. Texas benefits from a large retail pharmacy market with active competition among HEB Pharmacy (a Texas-specific chain), Walmart Neighborhood Market pharmacies, and the national chains. HEB Pharmacy's $4 and $8 generic drug programs historically have included finasteride, though formulary inclusions change. Patients should verify current pricing at their preferred pharmacy using GoodRx or the pharmacy's own price tool before filling.

The CDC's National Center for Health Statistics data on prescription drug spending confirms that out-of-pocket costs for generic drugs have declined over the prior decade, a trend that benefits Texas finasteride patients choosing the cash-pay route. [26]

What Prescribers and Guidelines Say

"Finasteride 1 mg per day is the most effective oral treatment available for male androgenetic alopecia and should be considered first-line pharmacotherapy in appropriate male patients," states the American Academy of Dermatology's 2023 clinical practice guidelines on hair loss (published in the Journal of the American Academy of Dermatology). [27]

The Endocrine Society's clinical practice guideline on androgen therapy notes that finasteride's mechanism, specifically inhibition of type II 5-alpha reductase and resulting reduction in dihydrotestosterone (DHT), is well characterized and the drug has a predictable pharmacokinetic profile after more than 25 years of post-market surveillance. [28]

Texas prescribers working in telehealth or primary care should document the indication clearly. A prescription written for "AGA" or "male pattern baldness" triggers cosmetic exclusions at most insurance processors. A prescription written for "androgenetic alopecia with documented Norwood-Hamilton scale progression" or referencing a dermatology consult note may improve adjudication outcomes, though commercial plan cosmetic exclusions can still apply regardless of documentation specificity.

The AUA guideline on BPH pharmacotherapy gives finasteride 5 mg a strong recommendation (Grade A, Level of Evidence 1b) for men with prostate volume >30 mL, a subset where 5-alpha reductase inhibitor therapy reduces the risk of acute urinary retention and the need for surgical intervention. [29] That clinical standing supports medical necessity arguments for BPH coverage under Texas commercial insurance and Medicaid managed care.